CD4 and neoplasm: More specific flow-cytometric analysis confirmed 4- to 5-fold increases in the percentage of tumor-infiltrating CD8+ and CD4+ T cells, with concomitant reduction in the percentage of CD4+/FoxP3+ regulatory T cells (Tregs).